Wickliffe Pharmaceutical, Inc.
483 response sent October 5, 2023 · Kentucky
- Pages
- 17
- FEI number
- 3002992930
In short: This is Wickliffe Pharmaceutical, Inc.'s written response to FDA, dated October 5, 2023, for its site in Kentucky (FEI 3002992930). It sets out the corrective actions the firm committed to.
Inside this response
This inspection in context
Questions about this response
When was Wickliffe Pharmaceutical, Inc. inspected by FDA?
This 483 response is dated October 5, 2023.
How do I get the full 483 response for Wickliffe Pharmaceutical, Inc.?
Download the original PDF from FDA Intel for $199, with no subscription. You also get an invoice PDF with the order.